At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Crohn’s Disease TRIDENT Study

Clinical Trial Title: 
Crohn’s disease TRIDENT study.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Ece Mutlu, MD
Clinical Trial Protocol Description: 

This study is looking into potential new investigational medications for people with Crohn’s disease. A description of this clinical trial will be available at, as required by U.S. law.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are at least 18 years of age.
  • Have had moderately to severely active Crohn’s disease symptoms for at least 3 months.
  • Are taking Crohn’s disease medication or have taken it in the past.

This is a partial list of elgibility requirements.

The total time in the study could be up to 34 weeks. If you qualify for the study and decide to join, you will receive study medication and health checks at no cost to you.

Clinical Trial Area: 
Digestive Disorders
Contact Phone: 
(312) 942-3466
Contact Name: 
GI Research